Acne Vulgaris. Acne vulgaris
Conditions
Interventions
Intervention 1: The patients in Intervention group were administered to take ?-3 Capsule (2 capsule daily) in addition to Doxycyclin Capsule (200 mg daily) plus topical antibactrial (Erythromycin Solu
Treatment - Drugs
For control group was administered Doxycyclin 200 mg daily and topical antibacterial (Erythromycin Solution 4% twice a day) for total 4 weeks.
The patients in Intervention group were administered to take ?-3 Capsule (2 capsule daily) in addition to Doxycyclin Capsule (200 mg daily) plus topical antibactrial (Erythromycin Solution for4%,twice
Sponsors
Kurdestan University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: acne- vulgaris patients have indication of systemic therapy treatment exclusion criteria:diabetes mellitus; hypertension ; significant pulmonary, hepatic or renal disease ; typical angina or myocardial infarction; use of antihypertensive, oral hypoglycemic or lipid lowering agent or anticoagulant drug; glucocorticoids equivalent to greater than 10 mg Prednisolone daily; all pregnant or lactating women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvment skin lesion such as comedone,papules,pustules,nodules. Timepoint: 1 month. Method of measurement: with count the facial lesion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement skin lesion such as comedone, papules, pustules, nodules. Timepoint: 1 month. Method of measurement: with count the facial lesion. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMilad Masaeli
Kurdestan University of Medical Science
Outcome results
None listed